Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M O'Kane

Showing results (141-150 of 229) with videos related to

Pageof 23
Sort By:
American Journal of Respiratory and Critical Care Medicine|April 13, 2021
Secreted Extracellular Cyclophilin A Is a Novel Mediator of Ventilator-induced Lung InjuryMarissa W Koh, Rhianna F Baldi, Sanooj Soni, et al.
Journal of Gastrointestinal Oncology|March 14, 2023
Whole-genome sequencing of 20 cholangiocarcinoma cases reveals unique profiles in patients with cirrhosis and primary sclerosing cholangitisNicholas Holzapfel, Amy Zhang, Woo-Jin Choi, et al.
Frontiers in Genetics|November 29, 2023
Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)Jannat Pervin, Mohammad Asad, Shaolong Cao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 17, 2019
Outcomes of Long-term Interval Rescreening With Low-Dose Computed Tomography for Lung Cancer in Different Risk CohortsReenika Aggarwal, Andrew C L Lam, Maureen McGregor, et al.
Hepatology (Baltimore, Md.)|February 18, 2022
Dynamic risk profiling of HCC recurrence after curative intent liver resectionTommy Ivanics, Carla Fiorella Murillo Perez, Marco P A W Claasen, et al.
Chest|August 23, 2012
Ventilator-associated pneumonia is characterized by excessive release of neutrophil proteases in the lungThomas S Wilkinson, Andrew Conway Morris, Kallirroi Kefala, et al.
British Journal of Cancer|July 22, 2022
Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancerMark K Doherty, Vincent C Tam, Mairéad G McNamara, et al.
Journal of Medicinal Chemistry|November 26, 1997
Synthesis and biological activity of a series of potent fluoromethyl ketone inhibitors of recombinant human calpain IS Chatterjee, M A Ator, D Bozyczko-Coyne, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2002
Mixed lineage kinase activity of indolocarbazole analoguesChikara Murakata, Masami Kaneko, George Gessner, et al.
British Journal of Cancer|May 21, 2019
A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trialGrainne M O'Kane, Shereen Ezzat, Anthony M Joshua, et al.
Pageof 23

Showing results (141-150 of 229) with videos related to

Sort By:
Pageof 23
American Journal of Respiratory and Critical Care Medicine|April 13, 2021
Secreted Extracellular Cyclophilin A Is a Novel Mediator of Ventilator-induced Lung InjuryMarissa W Koh, Rhianna F Baldi, Sanooj Soni, et al.
Journal of Gastrointestinal Oncology|March 14, 2023
Whole-genome sequencing of 20 cholangiocarcinoma cases reveals unique profiles in patients with cirrhosis and primary sclerosing cholangitisNicholas Holzapfel, Amy Zhang, Woo-Jin Choi, et al.
Frontiers in Genetics|November 29, 2023
Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)Jannat Pervin, Mohammad Asad, Shaolong Cao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 17, 2019
Outcomes of Long-term Interval Rescreening With Low-Dose Computed Tomography for Lung Cancer in Different Risk CohortsReenika Aggarwal, Andrew C L Lam, Maureen McGregor, et al.
Hepatology (Baltimore, Md.)|February 18, 2022
Dynamic risk profiling of HCC recurrence after curative intent liver resectionTommy Ivanics, Carla Fiorella Murillo Perez, Marco P A W Claasen, et al.
Chest|August 23, 2012
Ventilator-associated pneumonia is characterized by excessive release of neutrophil proteases in the lungThomas S Wilkinson, Andrew Conway Morris, Kallirroi Kefala, et al.
British Journal of Cancer|July 22, 2022
Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancerMark K Doherty, Vincent C Tam, Mairéad G McNamara, et al.
Journal of Medicinal Chemistry|November 26, 1997
Synthesis and biological activity of a series of potent fluoromethyl ketone inhibitors of recombinant human calpain IS Chatterjee, M A Ator, D Bozyczko-Coyne, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2002
Mixed lineage kinase activity of indolocarbazole analoguesChikara Murakata, Masami Kaneko, George Gessner, et al.
British Journal of Cancer|May 21, 2019
A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trialGrainne M O'Kane, Shereen Ezzat, Anthony M Joshua, et al.
Pageof 23